The store will not work correctly when cookies are disabled.
6,7-dihydroxy-3-(4-methylphenyl)-2H-chromen-2-one
ID: ALA3760002
PubChem CID: 15388819
Max Phase: Preclinical
Molecular Formula: C16H12O4
Molecular Weight: 268.27
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1ccc(-c2cc3cc(O)c(O)cc3oc2=O)cc1
Standard InChI: InChI=1S/C16H12O4/c1-9-2-4-10(5-3-9)12-6-11-7-13(17)14(18)8-15(11)20-16(12)19/h2-8,17-18H,1H3
Standard InChI Key: QKXGDIKKFAPHFJ-UHFFFAOYSA-N
Molfile:
RDKit 2D
20 22 0 0 0 0 0 0 0 0999 V2000
-2.6111 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.6111 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 -1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 -0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5929 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2964 1.4973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.0000 0.7486 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.2964 1.4973 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.6486 1.3517 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.9086 -1.5029 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9097 -3.0028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2093 -3.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5078 -3.0010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-6.5067 -1.5010 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-5.2071 -0.7519 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-7.5474 -3.6002 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.6321 1.3486 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.6321 -1.3486 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 2 0
3 4 1 0
4 5 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
4 9 2 0
9 10 1 0
1 10 1 0
1 11 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
12 17 2 0
15 18 1 0
2 12 1 0
7 19 1 0
6 20 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 268.27 | Molecular Weight (Monoisotopic): 268.0736 | AlogP: 3.18 | #Rotatable Bonds: 1 |
Polar Surface Area: 70.67 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 4 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 7.36 | CX Basic pKa: ┄ | CX LogP: 3.36 | CX LogD: 3.04 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.52 | Np Likeness Score: 0.22 |
References
1. Karataş MO, Uslu H, Alıcı B, Gökçe B, Gencer N, Arslan O, Arslan NB, Özdemir N.. (2016) Functionalized imidazolium and benzimidazolium salts as paraoxonase 1 inhibitors: Synthesis, characterization and molecular docking studies., 24 (6): [PMID:26879855] [10.1016/j.bmc.2016.02.012] |